The US is by far the world’s leading funder of biomedical research. But the Trump administration reportedly plans to ask ...

GLP-1 drugs like Ozempic, Mounjaro, Zepbound, originally for adults, are now prescribed for adolescents with obesity, showing ...

With its 2-star rating, we believe Lilly stock is overvalued compared with our long-term fair value estimate of $650 per ...

A group of renowned celebrities including Ishitta Arun, Lakshmi Manchu, Farah Khan, Vedang Raina, and Rashi Khanna gathered ...

Researchers at Karolinska Institutet in Stockholm, Sweden, have shown that specific blood biomarkers can predict development of dementia up to 10 years before symptoms appear. But their primary value ...

Staring down the barrel of a significant birthday, I vowed in January that this would be the year I finally found something ...

Doctors are learning more about the wider effects of the injections, from lowering blood pressure to helping people quit ...

Innovative treatments and devices, plus ongoing research conducted by aging experts, are providing us better insight into our ...

GLP-1 drugs like Ozempic, while effective for significant weight loss and reducing chronic disease risk, are associated with ...

Eli Lilly (NYSE:LLY) is a pharmaceutical titan with an $815 billion market cap, putting it on track to be the next $1 ...

Eli Lilly has requested Europe's drug regulator to re-examine its opinion on the company's Alzheimer's drug, the agency said ...

Novo Nordisk has notched a major legal win against compounding pharmacies that make copies of its diabetes and obesity drug ...